JCOG radiation therapy study group: History and achievements

Japanese Journal of Clinical Oncology

Volumn 41, Issue 11, 2011, Pages 1241-1243

  Ishikura, Satoshi ^a   Ito, Yoshinori ^b   Hiraoka, Masahiro ^c  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Clinical trials; Intensity modulated radiotherapy; Quality assurance; Radiation therapy; Stereotactic body radiotherapy

Indexed keywords

ACHIEVEMENT; ADVANCED CANCER; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL (TOPIC); DOSIMETRY; GENETIC ANALYSIS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; JAPAN; LARYNX CANCER; LUNG NON SMALL CELL CANCER; MEDICAL SOCIETY; NASOPHARYNX CANCER; PATIENT CARE; RADIATION DOSE FRACTIONATION; RADIATION PHYSICS; RADIATION THERAPY STUDY GROUP; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT INDICATION; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS AS TOPIC; HISTORY, 21ST CENTURY; HUMANS; LUNG NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 80155174117     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyr126     Document Type: Review

References (12)

1. Matsuo Y, Takayama K, Nagata Y, Kunieda E, Tateoka K, Ishizuka N, et al. Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 2007;68:416-25.
2. Advanced Technology Consortium. ATC ASTRO 2008 Brochure. http://atc.wustl.edu/publications/ASTRO2008/ATC_Brochure_ASTRO2008.pdf (9 July 2011, date last accessed).
3. Hiraoka M, Ishikura S. A Japan Clinical Oncology Group trial for stereotactic body radiation therapy of non-small cell lung cancer. J Thorac Oncol 2007;2:S115-7.
4. Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, et al. A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group (JCOG0403). Int J Radiat Oncol Biol Phys 2010;78:S27-8.
5. Nakamura K, Kodaira T, Shikama N, Kagami Y, Ishikura S, Shibata T, et al. Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study: Japan Clinical Oncology Group study (JCOG 0701). Jpn J Clin Oncol 2008;38:387-9.
6. Nishimura Y, Shibata T, Nakamatsu K, Kanamori S, Koike R, Okubo M, et al. A two-step intensity modulated radiation therapy method for nasopharyngeal cancer: The Kinki University experience. Jpn J Clin Oncol 2010;40:130-8.
7. Nishio T, Kunieda E, Shirato H, Ishikura S, Onishi H, Tateoka K, et al. Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan Clinical Oncology Group trial (JCOG0403). Phys Med Biol 2006;51:5409-17.
8. Toita T, Ohno T, Kaneyasu Y, Uno T, Yoshimura R, Kodaira T, et al. A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer. Jpn J Clin Oncol 2010;40:456-63.
9. Toita T, Ohno T, Kaneyasu Y, Kato T, Uno T, Hatano K, et al. A consensus-based guideline defining clinical target volume (CTV) for primary disease in external beam radiotherapy for intact uterine cervical cancer. Jpn J Clin Oncol 2011;41:1119-26.
10. Sanuki-Fujimoto N, Ishikura S, Hayakawa K, Kubota K, Nishiwaki Y, Tamura T. Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202. Radiat Oncol 2009; 4:16.
11. Sanuki N, Ishikura S, Shinoda M, Ito Y, Hayakawa K, Ando N. Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303. Int J Clin Oncol 2011, doi:10.1007/s10147-011-0264-9.
12. Ishikura S. Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care. Jpn J Clin Oncol 2008;38:723-9.